Health Center COVID-19 Survey

National Summary Report

Latest data from January 14, 2022

HRSA uses the information collected to: optimize COVID-19 testing and vaccination; track health center capacity and the impact of COVID-19 on operations, patients, and staff; and better understand training and technical assistance, funding, and other health center resource needs.

Health Center COVID-19 Survey Tool Questions

Health Center COVID-19 Survey Tool User Guide

Health Center Program Look-Alike Survey Data for COVID-19

COVID-19 Health Center Survey Interactive Data Dashboards

View cumulative vaccination data nationally; by state, territory, and freely associated state; and among patients identified as racial and/or ethnic minorities. New data views: total vaccinations (all sources) and Health Center Vaccine Program (federal allocations only).

View operational data, including testing capacity, vaccinations initiated and completed, temporary closures, staff ability to work, and visits conducted virtually.

View COVID-19 testing data by race/ethnicity.

Note: The dashboard data are updated weekly using Health Center COVID-19 Survey data.

Number of Health Center respondents = 1089 (79% of all Health Centers)

Data represent information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 864,274
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 64.24%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 291,458
Racial and/or Ethnic Minority Patients 66.53%

Patients Tested by Race and Ethnicity

Race/Ethnicity Patients Tested by race and ethnicity, Virus Detection (PCR, antigen)2 Patients Tested Positive by race and ethnicity, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 30.70% 28.92%
White, Hispanic/Latino Patients 21.78% 24.53%
Black/African American, Non-Hispanic/Latino Patients 16.02% 15.75%
Black/African American, Hispanic/Latino Patients 1.10% 1.28%
Asian Patients3 3.02% 2.70%
American Indian/Alaska Native Patients3 1.13% 1.05%
Native Hawaiian/Other Pacific Islander Patients3 0.95% 0.89%
Patients with More Than One Race3 3.24% 3.08%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 7.92% 8.21%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 2.57% 2.25%
Unreported/Refused to Report Race and Ethnicity 11.57% 11.34%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 139,313
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 82.95%
COVID-19 Immunization Series Completed 110,193
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 82.22%
COVID-19 Immunization Series Additional 305,563
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 76.96%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 14.56% 15.15% 20.27%
White, Hispanic/Latino Patients 29.91% 28.12% 23.41%
Black/African American, Non-Hispanic/Latino Patients 12.60% 12.43% 9.16%
Black/African American, Hispanic/Latino Patients 1.19% 1.17% 0.96%
Asian Patients3 4.52% 7.21% 12.94%
American Indian/Alaska Native Patients3 1.02% 0.92% 1.80%
Native Hawaiian/Other Pacific Islander Patients3 1.10% 1.24% 1.48%
Patients with More Than One Race3 3.81% 4.59% 4.77%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 16.67% 14.40% 13.17%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 2.43% 2.50% 2.51%
Unreported/Refused to Report Race and Ethnicity 12.19% 12.29% 9.52%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 18.09%
1 to 24 Hours 22.41%
More Than 24 Hours 57.76%
N/A 1.74%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 4.87%
Staffing to administer the vaccine 45.45%
Vaccine confidence 29.29%
Vaccine storage capacity 2.39%
Vaccine supply 4.50%
Other 5.42%
None 30.85%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 21.12%
Average Percent of Health Center Visits Conducted Virtually 21.92%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 34.99%
Number of Mobile Van Sites 356
Number of Pop-up Clinics 1,023
Number of School-Based Vaccination Sites 413
Number of Family Vaccination Clinics 1,075

Monoclonal Antibody Therapy

Metrics Value
Percent of Health Centers Providing Access to Monoclonal Antibody Therapy 60.88%
Number of Doses of Monoclonal Antibodies Administered 3,310

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 10.28%
Refer patients to another organization that provides monoclonal antibody therapies 53.17%
None 39.12%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 11.94%
Patient awareness/education 5.23%
Staffing capacity 18.46%
Therapy administration/onsite logistics 17.08%
Other 5.05%
None 60.88%

Test Kit Distribution

Metrics Value
Percent of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program 26.91%
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program 1,081,155

Test Kit Distribution Methods4

Metrics Value
Provide to Existing Health Center Patients 83.28%
Provide to General Public Who Came to the Health Center 60.75%
Provide at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 25.26%
Provide at Other Community Events 23.55%
Provide through direct outreach to specific populations (i.e., individuals experiencing homelessness, MSAWs, residents of public housing, individuals with limited English proficiency) 32.08%
Other 30.03%

Oral Antiviral Medication Distribution

Metrics Value
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program 59
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication5 63.02%

Oral Antiviral Medication Distribution by Race and Ethnicity5

Race/Ethnicity Value
White, Non-Hispanic/Latino Patients 23.49%
White, Hispanic/Latino Patients 49.52%
Black/African American, Non-Hispanic/Latino Patients 0.00%
Black/African American, Hispanic/Latino Patients 0.32%
Asian Patients3 3.81%
American Indian/Alaska Native Patients3 1.11%
Native Hawaiian/Other Pacific Islander Patients3 0.48%
Patients with More Than One Race3 1.90%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 5.87%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 0.48%
Unreported/Refused to Report Race and Ethnicity 5.40%

Oral Antiviral Medication Distribution by Special/Vulnerable Population5

Metrics Value
Migratory/Agricultural Workers 0.79%
Patients Experiencing Homelessness 1.27%
Patients Who Are Residents of Public Housing 6.19%
Patients with Limited English Proficiency 10.95%
Children Under 18 Years of Age 0.32%

 

Results from States and Territories

Select a measure on the dropdown menu to view by state or territory.

1 The reported number of patients tested does not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.

5 Percentages are calculated using the number of health centers that have distributed courses of COVID-19 oral antiviral medication received through the HRSA Health Center COVID-19 Therapeutics Program as the denominator.

Date Last Reviewed:  January 2022